ACADIAN ASSET MANAGEMENT LLC

Position in LXRX — Lexicon Pharmaceuticals, Inc.

CIK 916542 Boston, MA

Position in LXRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,671,880

+$977,231 QoQ

Shares Held

696,617

+56.4% QoQ

Ownership

0.157%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 149 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. LXRX ranks #52 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,671,880	696,617	+56.4%	Shares	Defined	2026-08-13
2026-03-31	$694,649	445,288	-30.4%	Shares	Defined	2026-05-13
2025-12-31	$736,149	640,130	+1634.5%	Shares	Defined	2026-02-10
2025-09-30	$49,821	36,905	-93.6%	Shares	Defined	2025-11-13
2025-03-31	$263,896	573,688	+889.0%	Shares	Defined	2025-05-21
2024-09-30	$91,070	58,007	-87.5%	Shares	Defined	2024-11-12
2021-03-31	$2,713,677	462,296	-72.7%	Shares	Defined	2021-05-11
2020-12-31	$5,793,599	1,694,035	-8.6%	Shares	Defined	2021-02-11
2020-09-30	$2,670,206	1,854,310	+11.5%	Shares	Defined	2020-11-09
2020-06-30	$3,325,852	1,662,926	+54.5%	Shares	Defined	2020-08-12
2020-03-31	$2,098,318	1,076,061	—	Shares	Defined	2020-05-11
No filing history on record for this holder in this stock.